Arshi Khanam

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Topics

Prognostic Factors

Immune Response

Regulatory T Cells

Top Venues

Journal of translational medicine

International journal of molecular sciences

Liver international : official journal of the International Association for the Study of the Liver

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Alip Ghosh, Joel V Chua, Shyam Kottilil
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. Journal of translational medicine 21 (1) (2023)
Arshi Khanam, Hector Gutiérrez-Barbosa, Kirsten E Lyke, Joel V Chua
Immune-Mediated Pathogenesis in Dengue Virus Infection. Viruses 14 (11) (2022)
Arshi Khanam, Shyamasundaran Kottilil
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? International journal of molecular sciences 24 (1) (2022)
Arshi Khanam, Shyamasundaran Kottilil
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? International journal of molecular sciences 24 (1) (2022)
Arshi Khanam, Shyamasundaran Kottilil
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? International journal of molecular sciences 24 (1) (2022)
Arshi Khanam, Joel V Chua, Shyamasundaran Kottilil
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. International journal of molecular sciences 22 (11) (2021)
Arshi Khanam, Paul G Saleeb, Shyamasundaran Kottilil
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 10 (5) (2021)
Arshi Khanam, Shyamasundaran Kottilil, Eleanor Wilson
Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus. Scientific reports 10 (1) (2020)
Arshi Khanam, Nirupama Trehanpati, Shiv Kumar Sarin
Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure. Liver international : official journal of the International Association for the Study of the Liver 39 (6) (2019)